Bentos, John Mark H.
HRN: 25-41-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/30/2024
07/06/2024
IV INFUSION
1.5gm
Q6
T/c Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes